Mark Ingham's high conviction buy call: Ever expensive Aspen suddenly cheap

Loading player...
After peaking at almost R450 early last year, the share price of Aspen Pharmacare has since been in steady retreat and is currently trading below R300. But while traders have been seeking shelter, independent investment analyst Mark Ingham is attracted by Mr Market's depression. He now regards Aspen shares as an excellent buying opportunity, rating his call as "high conviction". Ingham puts Aspen's fair value at R390 a share which means the current price offers today's buyers a significant margin of safety. In this in-depth interview Ingham unpacks the attraction of the R130bn market cap stock which has grown into a multinational operation with only around one fifth of its business in South Africa. Learn more about your ad choices. Visit megaphone.fm/adchoices
2 Nov 2016 2AM English South Africa Investing · Business News

Other recent episodes

To study or to start a business? The choice that built Bubbadue

More than one in 10 university graduates in South Africa cannot find a job. With an economy that creates far too few jobs for the people entering it, and AI starting to eat into white-collar work, many school leavers and their parents are asking whether a degree is still the…
20 Nov 5AM 14 min

BN Edge | Michael Beaumont on ActionSA's coalition hand and the DA standoff

Michael Beaumont has been called the power behind ActionSA's throne, and he's the man running its coalition talks across Gauteng. Speaking to Alec Hogg hours before ActionSA's first sit-down with the DA, he said the DA had never once come to the table until then, and that his party had…
19 Nov 9AM 50 min